Vertoro
Year of investment: 2018
Vertoro is developing a technology to enable the production of high-value applications such as Crude Lignin Oil (CLO) and char, from lignin, a waste bi-product of biofuel and paper production, thereby improving the economics of biofuels and reducing dependence on fossils.
Corporis Medical
Year of investment: 2017
Health Value Creation is developing two surgical devices, a diagnostic tool and a trocar closure device. The first device helps prevent anastomotic leakages after bowel surgery by predicting the quality of the anastomosis during surgery, thereby reducing post-operative complications and lowering healthcare costs. The second device is a trocar closure device for faster, safer and more secure suturing after laparoscopic surgery, resulting in a reduction of the chances of wound herniation.
TripleMed
Year of investment: 2017
TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms.
For more information on the company and product(s), please refer to the following video:
Kriya Materials
Year of investment: 2017
Kriya Materials is an innovative coatings company that focuses on high value coating formulations. It develops and manufactures its own tailor-made nanoparticles which form the basis for a wide range of coatings with unique, high-end properties.
Applications include displays, solar panels, window films and glasses.
Matisse Pharmaceuticals
Year of investment: 2016
Ioniqa Technologies
Year of investment: 2015
Ioniqa Technologies has a patented technology that uses magnetic colloidal systems with nanoparticles to break down PET into a re-usable monomer. The unique feature of this technology is its ability to remove pigmentation which opens up the range of available PET feedstock that can be recycled economically.
Black Bear Carbon
Year of investment: 2015
Black Bear Carbon converts used tires into prime grade carbon black and green energy via a proprietary pyrolysis process. Black Bear is an example of the circular economy, addressing an important societal need to re-use resources and reduce CO₂ emission.
Cristal Therapeutics
Year of investment: 2014
Cristal Therapeutics (formerly known as Cristal Delivery) is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies, registered as CriPec®. Cristal Therapeutic’s mission is optimize the therapeutic performance of drugs and thereby improve patient care.
Nano4Imaging
Year of investment: 2011
Nano4Imaging produces and uses medical devices and implants visible for medical interventions to monitor their function (e.g under MRI). N4I’s products MRWire and MagnaFy are used for navigation to treat cardiovascular diseases and for radiotherapy.
For more information on the company and product(s), please refer to the following video: